Side-by-side financials for FEMY and MDLN. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | FEMY | MDLN |
|---|---|---|
| Market cap | - | $49.12 B |
| US-listed rank | - | #322 |
| Revenue (latest FY) | $2.29M | $28.43B |
| Net income (latest FY) | -$18.63M | $1.16T |
| Net margin | -812.3% | 4069.4% |
| P/E (trailing FY) | - | 0.0 |
| SEC filings | 312 | 103 |
In their latest fiscal years, FEMASYS INC reported $2.29M in revenue while Medline Inc. reported $28.43B.
Full pages: FEMASYS INC and Medline Inc., or browse the full rankings.